Quantitative sodium MRI of the mouse prostate

Magnetic Resonance in Medicine

Volumn 63, Issue 3, 2010, Pages 822-827

  Near, Jamie ^a,b   Bartha, Robert ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Cancer; Imaging; Mouse; Prostate; Sodium

Indexed keywords

IMAGING TECHNIQUES; MAMMALS; PIXELS; UROLOGY;

CANCER; HIGH RESOLUTION; ISOTROPIC RESOLUTION; MOUSE; PIXEL INTENSITIES; PROSTATE; RADIO FREQUENCY COILS; RADIO-FREQUENCY FIELDS;

SODIUM;

SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DENSITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FREQUENCY ANALYSIS; IMAGE ANALYSIS; MAGNETIC FIELD; MEASUREMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PROSTATE; QUANTITATIVE ANALYSIS; RADIOFREQUENCY; SIGNAL NOISE RATIO;

EID: 77649140809     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22196     Document Type: Article

References (23)

1. Thulborn KR, Davis D, Adams H, Gindin T, Zhou J. Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging. Magn Reson Med 1999;41:351-359.
2. Thulborn KR, Gindin TS, Davis D, Erb P. Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies. Radiology 1999;213:156-166.
3. Wang Y, Hu W, Perez-Trepichio AD, Ng TC, Furlan AJ, Majors AW, Jones SC. Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke 2000;31: 1386-1391; discussion 1392.
4. Ouwerkerk R, Jacobs MA, Macura KJ, Wolff AC, Stearns V, Mezban SD, Khouri NF, Bluemke DA, Bottomley PA. Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI. Breast Cancer Res Treat 2007;106:151-160.
5. Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 2003;227:529-537.
6. 23Na MR imaging. AJNR Am J Neuroradiol 2008;29:464-470.
7. Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho KS. Functional MR imaging of prostate cancer. Radiographics 2007;27:63-75; discussion 75-67.
8. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol 2006;13:57-59.
9. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate, 1: metabolic relationships. Prostate 1991;18:25-46.
10. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate, 2: hormonal relationships in normal and neoplastic prostate. Prostate 1991;19:181-205.
11. Chen J, Zhao HF, Xu ZS. The prostate has secretory dysfunction for category IIIA and IIIB prostatitis. J Urol 2007;177:2166-2169; discussion 2169.
12. Schiebler ML, Tomaszewski JE, Bezzi M, Pollack HM, Kressel HY, Cohen EK, Altman HG, Gefter WB, Wein AJ, Axel L. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 1989;172: 131-137.
13. Kahn T, Burrig K, Schmitz-Drager B, Lewin JS, Furst G, Modder U. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology 1989;173:847-851.
14. Kline RP, Wu EX, Petrylak DP, Szabolcs M, Alderson PO, Weisfeldt ML, Cannon P, Katz J. Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging. Clin Cancer Res 2000;6:2146-2156.
15. Mispelter J, Lupu M, Briguet A. NMR probeheads for biophysical and biomedical experiments. London, UK: Imperial College Press; 2006. 596 p.
16. Wang J, Qiu M, Yang QX, Smith MB, Constable RT. Measurement and correction of transmitter and receiver induced nonuniformities in vivo. Magn Reson Med 2005;53:408-417.
17. Christensen JD, Barrere BJ, Boada FE, Vevea JM, Thulborn KR. Quantitative tissue sodium concentration mapping of normal rat brain. Magn Reson Med 1996;36:83-89.
18. Shen GX, Boada FE, Thulborn KR. Dual-frequency, dual-quadrature, birdcage RF coil design with identical B1 pattern for sodium and proton imaging of the human brain at 1.5 T. Magn Reson Med 1997; 38:717-725.
19. Reddy R, Li S, Noyszewski EA, Kneeland JB, Leigh JS. In vivo sodium multiple quantum spectroscopy of human articular cartilage. Magn Reson Med 1997;38:207-214.
20. Constantinides CD, Gillen JS, Boada FE, Pomper MG, Bottomley PA. Human skeletal muscle: sodium MR imaging and quantificationpotential applications in exercise and disease. Radiology 2000;216: 559-568.
21. Boada FE, Shen GX, Chang SY, Thulborn KR. Spectrally weighted twisted projection imaging: reducing T2 signal attenuation effects in fast three-dimensional sodium imaging. Magn Reson Med 1997;38: 1022-1028.
22. Lenkinski RE, Katz-Brull R, Gaston SM, DeWolf WC, Reynolds HG. Multinuclear Imaging of Human Excised Prostate Specimens at 3T. Proc Intl Soc Magn Reson Med 2002;10 (Honolulu, USA).
23. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 1995;45:459-466.